cardiac-science-sells-its-diagnostics-cardiology-to-mortara

Cardiac Science sells its diagnostics unit to Mortara

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: Cardiac Science, an Opto Circuits group company, announced a definitive agreement signed on March 29, 2013, to sell its Diagnostic Cardiology product... Read more

good-news-for-cystic-acne-patients-dr

Dr Reddy's launch cystic acne generic Zenatane

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Hyderabad: Dr. Reddy's Laboratories launched Zenatane (isotretinoin) capsules in 20 mg and 40 mg in the US. The drug is a therapeutically equivalent generic version... Read more

supreme-court-of-india-rules-against-novartis-chronic-myeloid-leukemia-drug-glivec-or-gleevec-s-patent-image-source-novartis

Novartis in shock as Indian Supreme Court rules against...

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: The Supreme Court of India has ruled against Novartis in a historic seven-year legal battle involving Novartis' chronic myeloid leukemia drug, Glivec... Read more

imatinib-mesylate-branded-by-novartis-as-gleevec-in-the-us-and-as-glivec-in-china-and-india

All you need to know about Glivec

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 1 Comment

What is Glivec? Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, receptor tyrosine kinase, which is characteristic... Read more

keeping-its-fingers-crossed-novartis-awaits-supreme-court-of-india-s-verdict-on-the-historic-patent-case-of-its-chronic-myeloid-leukemia-drug-glivec-or-gleevec

Novartis awaits Supreme Court verdict on Glivec patent case...

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

New Delhi: India's apex judicial body will today pass its verdict on historic seven-year legal battle involving Novartis' chronic myeloid leukemia drug, Glivec (known... Read more

puducherry-where-a-major-part-of-the-movie-life-of-pi-has-been-shot-joins-hands-with-abbott-for-a-joint-health-program

Abbott to develop disease map for 'Life of Pi' village

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: The Government of Puducherry, a Union Territory of India where a major part of the Oscar winning Life of Pi movie has been shot, has signed a three-year... Read more

abexome-biosciences-and-bioneeds-join-hands-to-provide-pre-clinical-and-core-biology-services

Abexome collaborates with Bioneeds

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: Abexome Biosciences, an analytical solution provider to the biopharmaceutical industry and Bioneeds, a leading OECD GLP certified pre-clinical service... Read more

marketsandmarkets-global-biomaterials-market-will-reach-usd88

Biomaterials market will be worth $88.4 bn by 2017

  • Singapore
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new report by MarketsAndMarkets titled 'Biomaterials market and applications - Global forecasts to 2017', estimates the global market for biomaterials... Read more

the-big-question-to-collaborate-or-not-to

Ten top Indian life science collaborations of 2012

  • India
  • |
  • Analysis
  • |
  • By Vipul Murarka
  • |
  • 0 Comment

As the market for new drugs evolves, the methodologies for moving them into the market is changing and becoming more complex. Companies are increasingly relying... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X